Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

USP30 Inhibitor

Home DrugsUSP30 Inhibitor

USP30 Inhibitor

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS
US 2023312580 A1Applicant: MISSION THERAPEUTICS LTDPriority: 2020
EP
US
WO
4 publications
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
US 11535618 B2Applicant: FORMA THERAPEUTICS INCPriority: 2018
CN
US
3 publications
COMPOSITIONS AND METHODS FOR PREVENTING CARDIOMYOPATHY
EP 4604947 A2Applicant: OHIO STATE INNOVATION FOUNDATIONPriority: 2022
EP
WO
2 publications
USP30 inhibitor and application thereof
- CN 115038688 A
  Applicant: VINCENTRE BIOSCIENCES INCPriority: 2019
  CN
- CN 117836270 A
  Applicant: VINCENTRE BIOSCIENCES INCPriority: 2021
  CN
USP30 inhibitor compound, pharmaceutical composition as well as preparation method and application of USP30 inhibitor compound and pharmaceutical composition
CN 121698858 AApplicant: CHANGCHUN GENESCIENCE PHARMACEUTICALS CO LTDPriority: 2024
CN